F. Mbewe

发表

Addition of Single-Dose Tenofovir and Emtricitabine to Intrapartum Nevirapine to Reduce Perinatal HIV Transmission

B. Chi, J. Stringer, M. Sinkala, 2008, Journal of acquired immune deficiency syndromes.

Limiting Adverse Birth Outcomes in Resource-Limited Settings

Daniel J. Luckett, S. Cole, J. Stringer, 2019, Case Medical Research.

A Randomized Trial of Point-of-Care Early Infant Human Immunodeficiency Virus (HIV) Diagnosis in Zambia

B. Chi, J. Stringer, C. Kankasa, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention.

B. Chi, J. Stringer, G. Aldrovandi, 2009, AIDS research and human retroviruses.

Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitory drugs in women given intrapartum nevirapine for perinatal HIV prevention: An open-label randomized trial

B. Chi, J. Stringer, J. Safrit, 2008 .

CD4+ cell count and risk for antiretroviral drug resistance among women using peripartum nevirapine for perinatal HIV prevention

B. Chi, J. Stringer, N. Chintu, 2011, BJOG : an international journal of obstetrics and gynaecology.

Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial

B. Chi, J. Stringer, J. Safrit, 2007, The Lancet.

Risk of Adverse Birth Outcomes in Two Cohorts of Pregnant Women With HIV in Zambia

S. Cole, J. Stringer, D. Rouse, 2022, Epidemiology.

Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial

S. Cole, J. Stringer, Roman Goldenberg, 2021, The lancet. HIV.

A Randomised Trial of Point-of-Care Early Infant HIV Diagnosis

B. Chi, J. Stringer, C. Kankasa, 2020 .

Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial

S. Cole, J. Stringer, L. Mofenson, 2019, BMC Pregnancy and Childbirth.

Limiting adverse birth outcomes in resource-limited settings (LABOR): protocol of a prospective intrapartum cohort study

Daniel J. Luckett, S. Cole, J. Stringer, 2022, Gates open research.